These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35720963)

  • 1. The Texas Community-Engagement Research Alliance Against COVID-19 in Disproportionately Affected Communities (TX CEAL) Consortium.
    Seguin-Fowler RA; Amos C; Beech BM; Ferrer RL; McNeill L; Opusunju JJ; Spence E; Thompson EL; Torres-Hostos LR; Vishwanatha JK
    J Clin Transl Sci; 2022; 6(1):e64. PubMed ID: 35720963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the Texas Community-Engaged Statewide Consortium for the Prevention of COVID-19.
    Thompson EL; Beech BM; Ferrer RL; McNeil LH; Opusunju JJ; Seguin-Fowler RA; Spence EE; Torres-Hostos L; Amos CI; Desai P; Vishwanatha JK
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360949
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Casillas A; Rosas LG; Carson SL; Orechwa A; North G; AuYoung M; Kim G; Guereca JA; Ramers CB; Burke NJ; Corchado CG; Aguilar-Gaxiola S; Cheney A; Rabin BA; Stadnick NA; Oswald W; Cabrera A; Sorkin DH; Zaldivar F; Wong W; Yerraguntala AS; Vassar SD; Wright AL; Washington DL; Norris KC; Brown AF
    Front Health Serv; 2022; 2():935297. PubMed ID: 36925779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Information, Trust, and Risk Perception Across Diverse Communities in the United States: Initial Findings from a Multistate Community Engagement Alliance (CEAL).
    Walker RJ; Eisenhauer E; Thompson EL; Butler R; Metheny N; Barroso CS; Marino M
    Am J Public Health; 2024 Jan; 114(S1):S112-S123. PubMed ID: 38207271
    [No Abstract]   [Full Text] [Related]  

  • 5. School-Academic Partnerships in Support of Safe Return to Schools During the COVID-19 Pandemic.
    D'Agostino EM; Haroz EE; Linde S; Layer M; Green M; Ko LK
    Pediatrics; 2022 Feb; 149(12 Suppl 2):. PubMed ID: 34737180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Community-Engaged Research Strategies in Increasing COVID-19 Vaccinations in Targeted Communities: The Community Engagement Alliance (CEAL) Regional Teams.
    Price SM; Ferg R; Eisenhauer EW; Chansky MC; Opsomer JD
    Am J Public Health; 2024 Jan; 114(S1):S124-S127. PubMed ID: 38207259
    [No Abstract]   [Full Text] [Related]  

  • 7. Using Community Engagement and Geographic Information Systems to Address COVID-19 Vaccination Disparities.
    Wu TY; Yang X; Lally S; Rainville AJ; Ford O; Bessire R; Donnelly J
    Trop Med Infect Dis; 2022 Aug; 7(8):. PubMed ID: 36006269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-Based Organizations Leading Research Efforts: Preliminary Findings from the Chicagoland CEAL Program's COVID-19 Vaccine Uptake and Intention Survey.
    Thomas P; Bishop-Royse J; Lomahan S; Silva A; Murphy AM; Martin MA
    J Racial Ethn Health Disparities; 2024 Feb; ():. PubMed ID: 38383838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations.
    D'Agostino EM; Rosenberg LM; Richmond A; Damman A; Brown-Lowery C; Abbot-Grimes P; Siddiqui S; Fadika T; Ward M; Cooper M; Sutton S; Kenton L; Spaziano B; Kasper J; Barnes N; Hornik C
    BMC Public Health; 2023 Oct; 23(1):2121. PubMed ID: 37898741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Engagement Alliance (CEAL) Against COVID-19 Disparities: Academic-community partnership to support workforce capacity building among Arizona community health workers.
    Jiménez DJ; Gomez O; Meraz R; Pollitt AM; Evans L; Lee N; Ignacio M; Garcia K; Redondo R; Redondo F; Williamson HJ; Oesterle S; Parthasarathy S; Sabo S
    Front Public Health; 2023; 11():1072808. PubMed ID: 36817902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Capacity Building and Sustained Implementation Among a Statewide Coalition to Address Racial/Ethnic COVID-19 Disparities.
    Jones DM; Taylor E; Orloff M; Prewitt TE; Donald K; Cornell CE; Fagan P
    Am J Public Health; 2024 Jan; 114(S1):S59-S64. PubMed ID: 38207260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine.
    Riley AC; Campbell H; Butler L; Wisseh C; Nonyel NP; Shaw TE
    J Am Pharm Assoc (2003); 2021; 61(6):e2-e5. PubMed ID: 34147364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement Alliance.
    Craig LS; Sarpong DF; Peacock EM; Theall KP; Williams L; Al-Dahir S; Davis TC; Arnold CL; Williams A; Fields T; Wilson M; Krousel-Wood M
    Am J Med Sci; 2023 Oct; 366(4):254-262. PubMed ID: 37517691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations.
    Narayanasamy S; Veldman TH; Lee MJ; Glover WA; Tillekeratne LG; Neighbors CE; Harper B; Raghavan V; Kennedy SW; Carper M; Denny T; Tsalik EL; Reller ME; Kibbe WA; Corbie G; Cohen-Wolkowiez M; Woods CW; Petti CA
    J Clin Microbiol; 2023 Aug; 61(8):e0036723. PubMed ID: 37395655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of a National Cancer Institute-Designated Community Outreach and Engagement Program in Supporting Communities During the COVID-19 Pandemic.
    Austin JD; Burke K; Argov EJL; Hillyer GC; Schmitt KM; McDonald J; Shelton RC; Terry MB; Tehranifar P
    J Community Health; 2022 Oct; 47(5):862-870. PubMed ID: 35819548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina.
    Doherty IA; Pilkington W; Brown L; Billings V; Hoffler U; Paulin L; Kimbro KS; Baker B; Zhang T; Locklear T; Robinson S; Kumar D
    medRxiv; 2021 Feb; ():. PubMed ID: 33655265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines.
    Webb Hooper M; Nápoles AM; Pérez-Stable EJ
    J Gen Intern Med; 2021 Jul; 36(7):2130-2133. PubMed ID: 33754319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The excess burden of breast carcinoma in minority and medically underserved communities: application, research, and redressing institutional racism.
    Shinagawa SM
    Cancer; 2000 Mar; 88(5 Suppl):1217-23. PubMed ID: 10705358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community-partnered approach for diversity in COVID-19 vaccine clinical trials.
    Castellon-Lopez Y; Landovitz R; Ntekume E; Porter C; Bross R; Hilder R; Lucas-Wright A; Daar ES; Chavez P; Blades C; Carson S; Morris D; Vassar S; Casillas A; Brown A
    J Clin Transl Sci; 2023; 7(1):e23. PubMed ID: 36714798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.